http://orcid.org/0000-0002-7860-693X
Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Wenting Huang, Annie Lockard, Colleen F. Kelley, David P. Serota, Charlotte-Paige M. Rolle, Patrick S. Sullivan, Eli S. Rosenberg & Aaron J. Siegler. (2022) From declining PrEP to PrEP initiation as “first nature” – what changes PrEP initiation decisions among young, Black MSM. AIDS Care 34:3, pages 284-293.
Read now
Read now
Meghan E. McGrady, Ahna L. H. Pai & Lisa A. Prosser. (2021) Using discrete choice experiments to develop and deliver patient-centered psychological interventions: a systematic review. Health Psychology Review 15:2, pages 314-332.
Read now
Read now
Eliza M. Govender. (2021) Tailoring Communication to Increase the Promotion of Oral PrEP: A Culture-Centred Approach. Communicatio 47:1, pages 122-142.
Read now
Read now
Articles from other publishers (41)
Candice A. Sternberg, E. Valerie Daniel, Dora Marcelin, Maurice Junior Chery, Krisna Maddy, Danelle Richard, Tanya Thomas, Jovanka Ravix, Joshua Warner, Micaelle Titus, Aline Francois, Joseph Borick, Daniel J. Feaster, Susanne Doblecki-Lewis, Deborah L. Jones, Maria L. Alcaide & Sannisha K. Dale. (2023) Bon Sante (Good Health): Factors Influencing PrEP Use Among Haitians/Haitian Americans. Journal of Racial and Ethnic Health Disparities.
Crossref
Crossref
S. Wilson Beckham, Travis SanchezRebecca Fowler, Maria ZlotorzynskaMona Rai, Patrick SullivanVani VannappagariSupriya SarkarJennifer L. GlickAlex R. RinehartKeith RawlingsJohn F.P. Bridges. (2023) Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis. AIDS Patient Care and STDs 37:10, pages 495-503.
Crossref
Crossref
Alex Dubov, Frederick L. Altice, José I. Gutierrez, Jeffrey A. Wickersham, Iskandar Azwa, Adeeba Kamarulzaman, Kamal Gautam & Roman Shrestha. (2023) Pre-exposure prophylaxis service among men who have sex with men in Malaysia: findings from a discrete choice experiment. Scientific Reports 13:1.
Crossref
Crossref
Lorraine T. Dean, Zachary Predmore, Alexandra Skinner, Siena Napoleon, Philip A. Chan & Julia Raifman. (2023) Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men. AIDS and Behavior 27:8, pages 2606-2616.
Crossref
Crossref
Rahel Dawit, Zachary Predmore, Julia Raifman, Philip A. Chan, Alexandra Skinner, Siena Napoleon, Alexandra Zanowick-Marr, Danielle Le Brazidec, Alexi Almonte & Lorraine T. Dean. (2023) Identifying HIV PrEP Attributes to Increase PrEP Use Among Different Groups of Gay, Bisexual, and Other Men Who Have Sex with Men: A Latent Class Analysis of a Discrete Choice Experiment. AIDS and Behavior.
Crossref
Crossref
Christofer A. Rodriguez & Jason W. Mitchell. (2023) Use of Stated Preference Methods in HIV Treatment and Prevention Research in the United States: A Systematic Review. AIDS and Behavior 27:7, pages 2328-2359.
Crossref
Crossref
Lara Lorenzetti, Nhi Dinh, Ariane van der Straten, Virginia Fonner, Kathleen Ridgeway, Michelle Rodolph, Robin Schaefer, Heather‐Marie A. Schmidt & Rachel Baggaley. (2023) Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition. Journal of the International AIDS Society 26:S2.
Crossref
Crossref
Katie B. Biello, Pablo K. Valente, Daniel Teixeira da Silva, Willey Lin, Ryan Drab, Lisa Hightow‐Weidman, Kenneth H. Mayer & José A. Bauermeister. (2023) Who prefers what? Correlates of preferences for next‐generation HIV prevention products among a national U.S. sample of young men who have sex with men. Journal of the International AIDS Society 26:S2.
Crossref
Crossref
Daniel Grace, Mark GasparAlex WellsJad Sinno, Emerich DaroyaMichael MontessMark HullNathan J. LachowskyDarrell H.S. Tan. (2023) Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada. AIDS Patient Care and STDs 37:6, pages 306-315.
Crossref
Crossref
Steven A. John, Juan P. Zapata, Madeline Dang, Benedikt Pleuhs, Andrew O’Neil, Sabina Hirshfield, Jennifer L. Walsh, Andrew E. Petroll & Katherine G. Quinn. (2023) Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old. Scientific Reports 13:1.
Crossref
Crossref
Patrick Sean Sullivan, Eric Hall, Heather Bradley, Travis Sanchez, Cory R Woodyatt & Elizabeth S Russell. (2023) Estimating HIV Incident Diagnoses Among Men Who Have Sex With Men Eligible for Pre-exposure Prophylaxis but Not Taking It: Protocol and Feasibility Assessment of Data Sources and Methods. JMIR Research Protocols 12, pages e42267.
Crossref
Crossref
Claudia Cristina de Aguiar Pereira, Thiago Silva Torres, Paula Mendes Luz, Brenda Hoagland, Alessandro Farias, José David Urbaez Brito, Marcus Vinícius Guimarães Lacerda, Daila Alena Raenck Silva, Marcos Benedetti, Maria Cristina Pimenta, Beatriz Grinsztejn & Valdilea Gonçalves Veloso. (2023) Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in Brazil. The Lancet Regional Health - Americas 19, pages 100432.
Crossref
Crossref
Sarah E. Stansfield, Mia Moore, Marie-Claude Boily, James P. Hughes, Deborah J. Donnell & Dobromir T. Dimitrov. (2023) Estimating benefits of using on-demand oral prep by MSM: a comparative modeling study of the US and Thailand. eClinicalMedicine 56, pages 101776.
Crossref
Crossref
Liang Shang & Yanto ChandraLiang Shang & Yanto Chandra. 2023. Discrete Choice Experiments Using R. Discrete Choice Experiments Using R
43
58
.
Alexandra M. Minnis, Juliane Etima, Petina Musara, Erica N. Browne, Prisca Mutero, Doreen Kemigisha, Nyaradzo M. Mgodi, Clemensia Nakabiito, Mary Kate Shapley-Quinn, Marie C. D. Stoner, Miriam Hartmann, Nicole Macagna, Jeanna Piper & Ariane van der Straten. (2022) Couples’ Preferences for “2 in 1” Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe. AIDS and Behavior 26:12, pages 3848-3861.
Crossref
Crossref
Maxime Inghels, Hae-Young Kim, Frank Tanser, Anita Hettema, Shannon A. McMahon, Catherine E. Oldenburg, Sindy Matse, Stefan Kohler, Pascal Geldsetzer & Till Bärnighausen. (2022) PrEP uptake and delivery setting preferences among clients visiting six healthcare facilities in Eswatini. AIDS and Behavior 26:10, pages 3345-3355.
Crossref
Crossref
Luh Putu Lila Wulandari, Shi Yi He, Christopher K. Fairley, Benjamin R. Bavinton, Heather-Marie Schmidt, Virginia Wiseman, Rebecca Guy, Weiming Tang, Lei Zhang & Jason J. Ong. (2022) Preferences for pre-exposure prophylaxis for HIV: A systematic review of discrete choice experiments. eClinicalMedicine 51, pages 101507.
Crossref
Crossref
Jeb Jones, Justin Knox, Steven Meanley, Cui Yang, David W. Lounsbury, Terry T. Huang, Jose Bauermeister, Graciela Gonzalez-Hernandez, Victoria Frye, Christian Grov, Viraj Patel, Stefan D. Baral, Patrick S. Sullivan & Sheree R. Schwartz. (2022) Explorations of the Role of Digital Technology in HIV-Related Implementation Research: Case Comparisons of Five Ending the HIV Epidemic Supplement Awards. JAIDS Journal of Acquired Immune Deficiency Syndromes 90:S1, pages S226-S234.
Crossref
Crossref
Adedotun Ogunbajo, Alexander C. Tsai, Phyllis J. Kanki & Kenneth H. Mayer. (2022) Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa. AIDS and Behavior 26:7, pages 2363-2375.
Crossref
Crossref
Jose I. Gutierrez, David Vlahov, Alex Dubov & Frederick L. Altice. (2022) Preferences for Long-Acting and Alternative Modalities for PrEP among Military Men Who Have Sex with Men: Segmentation Results of an Adaptive Choice-Based Conjoint Analysis Study. Journal of Urban Health 99:2, pages 277-292.
Crossref
Crossref
Matthew A. Spinelli, Beatriz Grinsztejn & Raphael J. Landovitz. (2022) Promises and challenges. Current Opinion in HIV and AIDS Publish Ahead of Print.
Crossref
Crossref
Janice Y. C. Lau, Ngai-Sze Wong, Krystal C. K. Lee, Tsz-Ho Kwan, Grace C. Y. Lui, Denise P. C. Chan & Shui-Shan Lee. (2022) What makes an optimal delivery for PrEP against HIV: A qualitative study in MSM. International Journal of STD & AIDS 33:4, pages 322-329.
Crossref
Crossref
Rebecca Zimba, Chunki Fong, Madellena Conte, Abigail Baim‐Lance, McKaylee Robertson, Jennifer Carmona, Gina Gambone, Denis Nash & Mary Irvine. (2022) Provider preferences for delivery of HIV care coordination services: results from a discrete choice experiment. Journal of the International AIDS Society 25:3.
Crossref
Crossref
Janan J. Dietrich, Millicent Atujuna, Gugulethu Tshabalala, Stefanie Hornschuh, Mamakiri Mulaudzi, Michelle Koh, Nadia Ahmed, Richard Muhumuza, Andrew S. Ssemata, Kennedy Otwombe, Linda-Gail Bekker, Janet Seeley, Neil A. Martinson, Fern Terris-Prestholt & Julie Fox. (2021) A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa. BMC Health Services Research 21:1.
Crossref
Crossref
Darrell H. S. Tan, Jayoti Rana, Zavare Tengra, Trevor A. Hart, James Wilton & Ahmed M. Bayoumi. (2021) Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment. Scientific Reports 11:1.
Crossref
Crossref
Venkatesan Chakrapani, Peter A. Newman, Michael Cameron, Murali Shunmugam, Surachet Roungprakhon, Shruta Rawat, Dicky Baruah, Ruban Nelson, Suchon Tepjan & Riccardo Scarpa. (2021) Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment. AIDS and Behavior 25:10, pages 3074-3084.
Crossref
Crossref
Claudia Cristina de Aguiar Pereira, Thiago Silva Torres, Paula Mendes Luz, Brenda Hoagland, Alessandro Farias, Jose David Urbaez Brito, Marcus Vinícius Guimarães Lacerda, Daila Alena Raenck da Silva, Marcos Benedetti, Maria Cristina Pimenta, Beatriz Grinsztejn & Valdilea Gonçalves Veloso. (2021) Preferences for pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women at risk of HIV infection: a multicentre protocol for a discrete choice experiment in Brazil. BMJ Open 11:9, pages e049011.
Crossref
Crossref
Pedro B. Carneiro, Christopher Rincon & Sarit Golub. (2021) Predictors of Event-Driven Regimen Choice in Current PrEP Users and Sexual Behavior Characteristics of MSM Receiving Sexual Health Services in New York City. AIDS and Behavior 25:8, pages 2410-2418.
Crossref
Crossref
Mart van Dijk, John B. F. de Wit, Thomas E. Guadamuz, Joel E. Martinez & Kai J. Jonas. (2021) Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP. AIDS and Behavior 25:8, pages 2382-2390.
Crossref
Crossref
Alex Dubov, Adedotun Ogunbajo, Frederick L. Altice, Liana Fraenkel & Brian Distelberg. (2020) Development and Psychometric Evaluation of the PrEP Sexual Expectancies (PSEXS) Scale. AIDS and Behavior 25:4, pages 1192-1198.
Crossref
Crossref
Mart van Dijk, John B. F. de Wit, Rebecca Kamps, Thomas E. Guadamuz, Joel E. Martinez & Kai J. Jonas. (2020) Socio-Sexual Experiences and Access to Healthcare Among Informal PrEP Users in the Netherlands. AIDS and Behavior 25:4, pages 1236-1246.
Crossref
Crossref
Matthew E. Levy, Anya Agopian, Manya Magnus, Anthony Rawls, Jenevieve Opoku, Michael Kharfen, Alan E. Greenberg & Irene Kuo. (2021) Is Long-Acting Injectable Cabotegravir Likely to Expand PrEP Coverage Among MSM in the District of Columbia?. JAIDS Journal of Acquired Immune Deficiency Syndromes 86:3, pages e80-e82.
Crossref
Crossref
S. Wilson Beckham, Norah L. Crossnohere, Margaret Gross & John F. P. Bridges. (2020) Eliciting Preferences for HIV Prevention Technologies: A Systematic Review. The Patient - Patient-Centered Outcomes Research 14:2, pages 151-174.
Crossref
Crossref
Elena Bekerman, Stephanie Cox, Darius Babusis, Federico Campigotto, Moupali Das, Dan H Barouch, Tomas Cihlar & Christian Callebaut. (2021) Two-dose emtricitabine/tenofovir alafenamide plus bictegravir prophylaxis protects macaques against SHIV infection. Journal of Antimicrobial Chemotherapy 76:3, pages 692-698.
Crossref
Crossref
Jing Zhang, Jun‐Jie Xu, Hong‐Yi Wang, Xiao‐Jie Huang, Yao‐Kai Chen, Hui Wang, Zhen‐Xing Chu, Qing‐Hai Hu, Xiao‐Qing He, Yao Li, Lu‐Kun Zhang, Zhi‐Li Hu, Ran‐Tong Bao, Shang‐Cao Li, Hang Li, Hai‐Bo Ding, Yong‐Jun Jiang, Wen‐Qing Geng, Sean Sylvia & Hong Shang. (2021) Preference for daily versus on‐demand pre‐exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real‐world Oral PrEP Demonstration study. Journal of the International AIDS Society 24:2.
Crossref
Crossref
Richard Dunville, Christopher Harper, Michelle M. Johns, Melissa Heim Viox, Sabrina Avripas, Erin Fordyce, Michael Stern, Anna Schlissel, Rachel Carpenter & Stuart Michaels. (2021) Awareness and Willingness to Use Biomedical Prevention Strategies for HIV Among Sexual and Gender Minority Youth: Results From a National Survey. Journal of Adolescent Health 68:1, pages 199-206.
Crossref
Crossref
José A. Bauermeister, Julie S. Downs & Douglas S. Krakower. (2020) PrEP Product Acceptability and Dual Process Decision-Making Among Men Who Have Sex with Men. Current HIV/AIDS Reports 17:3, pages 161-170.
Crossref
Crossref
Alexandra M Minnis, Millicent Atujuna, Erica N Browne, Sheily Ndwayana, Miriam Hartmann, Siyaxolisa Sindelo, Nangamso Ngcwayi, Marco Boeri, Carol Mansfield, Linda‐Gail Bekker & Elizabeth T Montgomery. (2020) Preferences for long‐acting Pre‐Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. Journal of the International AIDS Society 23:6.
Crossref
Crossref
Jane M. Simoni, Kenneth Tapia, Sung-Jae Lee, Susan M. Graham, Kristin Beima-Sofie, Zahra H. Mohamed, Joan Christodoulou, Rodney Ho & Ann C. Collier. (2019) A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.. AIDS and Behavior 24:4, pages 1226-1236.
Crossref
Crossref
Alexandra M. Minnis, Elizabeth T. Montgomery, Sue Napierala, Erica N. Browne & Ariane van der Straten. (2019) Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products. JAIDS Journal of Acquired Immune Deficiency Syndromes 82:3, pages S222-S229.
Crossref
Crossref
Sarah Stansfield, Mia Moore, MC Boily, James P. Hughes, Deborah Donnell & Dobromir Dimitrov. (2022) Estimating Benefits from Using On-Demand Oral Prep by MSM: A Comparative Modeling Study of the US and Thailand. SSRN Electronic Journal.
Crossref
Crossref